ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 76 filers reported holding ENDOCYTE INC in Q2 2017. The put-call ratio across all filers is 1.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $28,702,000 | +32.7% | 1,616,058 | +3.1% | 0.00% | 0.0% |
| Q2 2018 | $21,633,000 | +4696.7% | 1,567,622 | +3061.9% | 0.00% | – |
| Q1 2018 | $451,000 | +526.4% | 49,579 | +190.3% | 0.00% | – |
| Q4 2017 | $72,000 | +200.0% | 17,079 | 0.0% | 0.00% | – |
| Q3 2017 | $24,000 | -11.1% | 17,079 | -2.8% | 0.00% | – |
| Q2 2017 | $27,000 | -98.4% | 17,579 | -97.3% | 0.00% | – |
| Q1 2017 | $1,650,000 | +4.3% | 641,476 | +3.4% | 0.00% | – |
| Q4 2016 | $1,582,000 | -15.4% | 620,248 | +2.7% | 0.00% | – |
| Q3 2016 | $1,869,000 | -2.7% | 603,959 | +1.0% | 0.00% | – |
| Q2 2016 | $1,920,000 | +3.2% | 597,725 | -0.2% | 0.00% | – |
| Q1 2016 | $1,860,000 | -41.6% | 598,888 | -24.7% | 0.00% | – |
| Q4 2015 | $3,187,000 | -11.0% | 795,504 | +1.7% | 0.00% | – |
| Q3 2015 | $3,582,000 | -10.8% | 782,060 | +1.1% | 0.00% | – |
| Q2 2015 | $4,016,000 | -13.4% | 773,668 | +4.4% | 0.00% | – |
| Q1 2015 | $4,639,000 | +25.5% | 740,944 | +26.1% | 0.00% | – |
| Q4 2014 | $3,697,000 | +3.1% | 587,575 | -0.4% | 0.00% | – |
| Q3 2014 | $3,587,000 | -10.1% | 590,111 | -2.6% | 0.00% | – |
| Q2 2014 | $3,992,000 | -67.0% | 605,674 | +19.4% | 0.00% | -100.0% |
| Q1 2014 | $12,081,000 | +24.6% | 507,415 | -48.4% | 0.00% | 0.0% |
| Q4 2013 | $9,696,000 | +41.6% | 983,085 | +91.4% | 0.00% | 0.0% |
| Q3 2013 | $6,848,000 | +2.0% | 513,707 | +0.5% | 0.00% | 0.0% |
| Q2 2013 | $6,711,000 | – | 511,203 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|